Histiocytosis X; follow-up of 43 cases

Area of Science:

• Pediatric Oncology
• Immunology
• Hematology

Background:

• Histiocytosis X, a rare group of disorders characterized by an overproduction of histiocytes.
• Understanding long-term outcomes and prognostic factors in pediatric Histiocytosis X is crucial for patient management.

Purpose of the Study:

• To analyze the long-term outcomes and identify prognostic factors for Histiocytosis X in children.
• To assess the prevalence of disabilities and specific complications in survivors.

Main Methods:

• Retrospective analysis of 43 pediatric cases of Histiocytosis X over a 29-year period.
• Evaluation of survival rates, disability prevalence, and specific clinical manifestations including pulmonary, endocrine, and growth parameters.

Main Results:

• A 67% survival rate was observed in 43 children under 12 with Histiocytosis X.
• Younger age at presentation and soft tissue involvement were linked to poorer prognosis.
• Pulmonary involvement was the primary cause of mortality; 14 patients developed diabetes insipidus, and 5 survivors had growth below the 3rd percentile.

Conclusions:

• Histiocytosis X in young children has a significant survival rate but often results in long-term disabilities.
• Early identification of risk factors like age and soft tissue involvement is vital for improving outcomes.
• Pulmonary complications and diabetes insipidus are significant concerns requiring vigilant monitoring in survivors.